Edward Cliff

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  

Edward Cliff
Mar 28, 2025, 11:15 | Blog
Edward Cliff: All things post-CAR-T malignancies on Blood Cancer Talks
Edward Cliff, Haematology Registrar at the Peter MacCallum Cancer Centre, shared a post on LinkedIn:…
Jul 27, 2024, 14:57 | Insight
Edward Cliff: The development and clinical trial design of T-cell lymphoma drugs pralatrexate and belinostat
Edward Cliff, Haematology Registrar at Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, shared a…
May 7, 2024, 10:54 | Career
Edward Cliff is starting a new position as Haematology Registrar at Peter MacCallum Cancer Centre and The Royal Melbourne Hospital!
Edward Cliff, Haematology Registrar at Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, shared…
Feb 5, 2024, 13:51 | Blog
Edward Cliff: Congrats to my co-registrar Shin Wai for leading this in-depth analysis of PET radiomics to predict lymphoma relapse histology
Edward Cliff, Fellow at Harvard Medical School and Brigham & Women’s Hospital, made the following…
Nov 18, 2023, 23:57 | Blog
Edward Cliff: Excited to share our work on accelerated approval and NCCN guidelines, out today
Edward Cliff, Fellow at Harvard Medical School and Brigham & Women’s Hospital, made the following…
Nov 14, 2023, 00:54 | Blog
Edward Cliff: We highlight the overuse of terms such as 'tolerable', 'manageable' and 'acceptable' in reports of clinical trials
Edward Cliff, Fellow at Harvard Medical School and Brigham & Women's Hospital, made the following…
Oct 17, 2023, 01:19 | Drugs
Edward Cliff: POLARIX trial of antibody-drug conjugate polatuzumab vedotin in diffuse large B-cell lymphoma.
Edward Cliff, Postdoctoral Research Fellow at Harvard Medical School, shared on LinkedIn: “Just out in…
Oct 13, 2023, 12:29 | Blog
Edward Cliff: I’m delighted to share that I was selected to be an FDA American Association of Cancer Research Oncology Education Fellow for 2023-2024.
Quoting Edward Cliff, Postdoctoral Research Fellow at Harvard Medical School, on LinkedIn: “I’m delighted to…
All: 8 Posts: 1 - 100
Special Coverage